Difference in weight loss based on ethnicity, age and comorbidity status in a publicly funded adult weight management centre: 1-year results

2013 ◽  
Vol 3 (1-2) ◽  
pp. 21-31 ◽  
Author(s):  
R. H. Liu ◽  
S. Wharton ◽  
A. M. Sharma ◽  
C. I. Ardern ◽  
J. L. Kuk
Keyword(s):  
Weight Loss ◽  
Weight Management ◽  
Publicly Funded ◽  
Adult Weight ◽  
Comorbidity Status

scholarly journals Edmonton Obesity Staging System Prevalence and Association with Weight Loss in a Publicly Funded Referral-Based Obesity Clinic

2015 ◽  
Vol 2015 ◽  
pp. 1-7 ◽  
Author(s):  
Karissa L. Canning ◽  
Ruth E. Brown ◽  
Sean Wharton ◽  
Arya M. Sharma ◽  
Jennifer L. Kuk
Keyword(s):  
Risk Factors ◽  
Weight Loss ◽  
Weight Management ◽  
Treatment Time ◽  
Staging System ◽  
Publicly Funded ◽  
Weight Outcomes ◽  
Psychological Comorbidities ◽  
Similar Weight ◽  
Edmonton Obesity Staging System

Objectives. To determine the distribution of EOSS stages and differences in weight loss achieved according to EOSS stage, in patients attending a referral-based publically funded multisite weight management clinic.Subjects/Methods. 5,787 obese patients were categorized using EOSS staging using metabolic risk factors, medication use, and severity of doctor diagnosis of obesity-related physiological, functional, and psychological comorbidities from electronic patient files.Results. The prevalence of EOSS stages 0 (no risk factors or comorbidities), 1 (mild conditions), 2 (moderate conditions), and 3 (severe conditions) was 1.7%, 10.4%, 84.0%, and 3.9%, respectively. Prehypertension (63%), hypertension (76%), and knee replacement (33%) were the most common obesity-related comorbidities for stages 1, 2, and 3, respectively. In the models including age, sex, initial BMI, EOSS stage, and treatment time, lower EOSS stage and longer treatment times were independently associated with greater absolute (kg) and percentage of weight loss relative to initial body weightP<0.05.Conclusions. Patients attending this publicly funded, referral-based weight management clinic were more likely to be classified in the higher stages of EOSS. Patients in higher EOSS stages required longer treatment times to achieve similar weight outcomes as those in lower EOSS stages.

scholarly journals Receptivity to Bariatric Surgery in Qualified Patients

2016 ◽  
Vol 2016 ◽  
pp. 1-6 ◽  
Author(s):  
Michael Fung ◽  
Sean Wharton ◽  
Alison Macpherson ◽  
Jennifer L. Kuk
Keyword(s):  
Social Support ◽  
Bariatric Surgery ◽  
Weight Loss ◽  
Weight Management ◽  
Diabetes Management ◽  
Effective Intervention ◽  
Publicly Funded ◽  
Factors Influencing ◽  
Positive Social Support ◽  
Weight Loss Success

Objectives. Bariatric surgery has been shown to be an effective intervention for weight loss and diabetes management. Despite this, many patients qualified for bariatric surgery are not interested in undergoing the procedure. The objective of this study is to determine the factors influencing receptivity to bariatric surgery among those who qualify for the procedure.Methods. Patients attending a publicly funded weight management clinic who qualified for bariatric surgery were asked to complete an elective questionnaire between February 2013 and April 2014.Results. A total of 371 patients (72% female) completed the questionnaire. Only 87 of 371 (23%) participants were interested in bariatric surgery. Individuals interested in bariatric surgery had a higher BMI (48.0 versus 46.2 kg/m2,P=0.03) and believed that they would lose more weight with surgery (51 versus 44 kg,P=0.0069). Those who scored highly on past weight loss success and financial concerns were less likely to be interested in bariatric surgery, whereas those who scored highly on high receptivity to surgery and positive social support were more likely to be interested in bariatric surgery.Conclusion. Although participants overestimated the effect of bariatric surgery on weight loss, most were still not interested in bariatric surgery.

scholarly journals Predictors of Weight Loss and Weight Gain in Weight Management Patients during the COVID-19 Pandemic

2021 ◽  
Vol 2021 ◽  
pp. 1-8
Author(s):  
Jennifer L. Kuk ◽  
Rebecca A. G. Christensen ◽  
Elham Kamran Samani ◽  
Sean Wharton
Keyword(s):  
Weight Loss ◽  
Body Weight ◽  
Weight Gain ◽  
Weight Management ◽  
Management Program ◽  
Publicly Funded ◽  
Electronic Survey ◽  
Survey Results ◽  
Predictors Of Weight Loss ◽  
Management Changes

Objective. To examine the associations between patient struggles, health, and weight management changes during the COVID-19 pandemic. Methods. 585 patients attending a publicly funded clinical weight management program responded to an electronic survey. Results. Over half of the patients reported worsened overall health, mental health, physical activity, or diet during the pandemic. Approximately 30% of patients lost ≥3% of their body weight and 21% gained ≥3% of their body weight between March and July of the pandemic. Reports of social isolation was associated with increased odds for weight loss in women (OR = 2.0, 1.2–3.3), while low motivation (OR = 1.9, 1.0–3.7), depression (OR = 2.5, 1.0–6.3), and struggles with carbohydrate intake (OR = 2.1, 1.0–4.3) were associated with weight gain. Cooking more at home/eating less take out was associated with increased likelihood of weight loss (OR = 2.1, 1.1–3.9) and lower odds for weight gain (OR = 0.2, 0.1 to 0.97). Working from home was not associated with weight loss or weight gain ( P > 0.6 ). Conclusion. The COVID-19 pandemic is associated with certain factors that may facilitate weight loss and other factors that promote weight gain. Thus, depending on the patient experience during the pandemic, prevention of weight gain may be more appropriate than weight loss.

scholarly journals Type 2 diabetes is an independent predictor of weight loss in Tier 3 Weight Assessment and Management Services

2020 ◽  
Vol 20 (2) ◽  
pp. 117-121
Author(s):  
Aliya Syahreni Prihartadi* ◽  
Giovanna Impelliziere Licastro* ◽  
Harshal Deshmukh ◽  
Sufyan Benamer ◽  
Kyaw Linn ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Weight Loss ◽  
Weight Management ◽  
Management Service ◽  
Adult Weight ◽  
Weight Management Service ◽  
Predictors Of Weight Loss ◽  
Tier 3

Introduction: A specialist weight management service provides an effective treatment option for severe obesity; however, there are limited data exploring the baseline predictors of response and effect on HbA1c following engagement with the service.Methods: We used prospective data from the regional weight management services within the Hull University Teaching Hospitals NHS Trust Tier 3 Obesity Programme. Data were available for 249 patients referred to the service. T-tests were used for univariate baseline characteristics of those with and without 5% weight loss after engagement with the service. Logistic regression analysis was used to identify independent predictors of weight loss at 12 months.Results: A total of 309 patients were referred to the Tier 3 adult weight management service, of which 249 (80.6%) participated in the programme and had at least one follow-up. The median age of the study population was 46 years (range 36–55) and consisted of 66% females with a median baseline body mass index of 44 kg/m2 (range 42–45). The prevalence of type 2 diabetes was 31%, hypertension was 35%, gastro-oesophageal reflux disease was 34% and osteoarthritis was 29%. The median baseline weight on enrolment in the programme was 126 kg (range 115–138). During the follow-up period of 1 year, the median weight fell to 120.5 kg at 3 months, 119.6 kg at 6 months, 117.7 kg at 9 months and 117.5 kg at 12 months. The median HbA1c fell from a baseline of 60.25 mmol/mol to 54.4 mmol/mol during the follow-up period. Sixty-four patients had a baseline HbA1c of >53 mmol/mol (7% HbA1c), which fell to <53 mmol/mol in 21% of patients during the follow-up period. In the logistic regression model, higher age (OR 1.05, p=0.0001), type 2 diabetes (OR 2.54, p=0.002) and dyslipidaemia (OR 2.21, p=0.03) were independently associated with more than 5% weight loss at 12 months follow-up.Conclusion: Engagement with Tier 3 adult weight management is associated with significant weight loss and improvement in glycaemic control in a large proportion of patients at one year. Higher age, diabetes and dyslipidaemia at baseline are independent predictors of weight loss on the Tier 3 weight management service.

Family Meal Practices and Weight Talk Between Adult Weight Management and Weight Loss Surgery Patients and Their Children

2020 ◽  
Vol 52 (6) ◽  
pp. 579-587 ◽  
Author(s):  
Keeley J. Pratt ◽  
Joseph A. Skelton ◽  
Kristina H. Lewis ◽  
Christopher A. Taylor ◽  
Colleen Spees ◽  
...  
Keyword(s):  
Weight Loss ◽  
Weight Management ◽  
Weight Loss Surgery ◽  
Adult Weight ◽  
Family Meal

scholarly journals Class 3 Obesity in a Multidisciplinary Metabolic Weight Management Program: The Effect of Preexisting Type 2 Diabetes on 6-Month Weight Loss

2020 ◽  
Vol 2020 ◽  
pp. 1-9
Author(s):  
David M. Medveczky ◽  
Raymond Kodsi ◽  
Kathryn Skelsey ◽  
Kathy Grudzinskas ◽  
Flavia Bueno ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Weight Loss ◽  
Weight Management ◽  
Management Program ◽  
Publicly Funded ◽  
Percentage Weight ◽  
Weight Loss Outcomes ◽  
Potential Weight ◽  
Hospital Clinic

Introduction. Class 3 obesity (BMI≥40 kg/m2) is a growing health problem worldwide associated with considerable comorbidity including Type 2 diabetes mellitus (T2DM). The multidisciplinary medical management of obesity can be difficult in T2DM due to potential weight gain from medications including sulphonylureas and insulin. However, newer weight-neutral/losing diabetes medications can aid additional weight loss. The aim of this study was to compare weight loss outcomes of patients with and without T2DM, and in patients with T2DM, to compare diabetes outcomes and change in medications at 6 months. Methods. All patients entering a multidisciplinary weight management metabolic program in a publicly funded hospital clinic in Sydney between March 2018 and March 2019, with BMI≥40 kg/m2 and aged ≥18 years were included. Data was collected from patient clinical and electronic notes at baseline and 6 months. Results. Of the 180 patients who entered the program, 53.3% had T2DM at baseline. There was no difference in percentage weight loss in those with or without T2DM (4.2±4.9% vs. 3.6±4.7%, p=0.35). Additionally, T2DM patients benefited from a 0.47% reduction in HbA1c (p<0.01) and a reduction in the number of medications from baseline to 6 months (1.8±1.0/patient vs. 1.0±1.2/patient, p<0.001). T2DM patients who started on weigh-neutral/losing medications in the program lost more weight than those started on weight-gaining medications (7.7±5.3% vs. 2.4±3.8%, p=0.015). Conclusions. Patients with class 3 obesity had significant weight loss at 6 months in this program. Patients with T2DM at baseline had comparable weight loss at 6 months, a significant improvement in glycaemic control, and a reduction in diabetes medication load. Additionally, patients with T2DM who were started on weight-neutral/losing medications lost significantly more weight than those started on weight-gaining medications, and these medications should be preferentially used in class 3 obesity and comorbid T2DM.

Abstract #615: Hispanic People Achieve Clinically Significant Weight loss with Liraglutide 3.0 Mg for Weight Management

2015 ◽  
Vol 21 ◽  
pp. 121
Author(s):  
Patrick O’Neil ◽  
W. Timothy Garvey ◽  
J. Michael Gonzalez-Campoy ◽  
Pablo Mora ◽  
Rafael Violante Ortiz ◽  
...  
Keyword(s):  
Weight Loss ◽  
Weight Management ◽  
Significant Weight Loss ◽  
Hispanic People ◽  
Clinically Significant
Sign in / Sign up

Export Citation Format

Share Document